A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.
NCT: NCT06150209 · WITHDRAWN
Brief Summary
The Goal of this study is to evaluate the wound volume reduction rate and the time to closure when using Vendaje to manage diabetic wounds. The participants will be treated weekly for up to 12 weeks. The data will be compared to retrospective Standard of care data from similarly controlled studies
Frequently Asked Questions
What is A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.?
A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje. is a clinical trial registered under NCT06150209. Current status: WITHDRAWN.
What is the status of NCT06150209?
The current status of NCT06150209 (A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.) is: WITHDRAWN.
When did A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje. start?
A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje. started on 2024-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.